Chemomab Therapeutics Ltd DRC (CMMB)

US · Healthcare · Biotechnology

$1.32+5.60%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-2.2M

EPS

$-1.40

EPS estimate

$0.00

Market cap

$10.1M

Forward P/E

12.9

P/B

1.00

Book value

$1.20

EPS (TTM)

$-1.04

52-week high

$2.99

52-week low

$0.92

50-day MA

$1.84

200-day MA

$1.75

Beta

0.79

Analysts rate Chemomab Therapeutics Ltd DRC a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $5.00.

Insiders

7.03%

Institutions

24.47%

Fund	Stake
Advisory Services Network, LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Chemomab Therapeutics Ltd DRC — free to start.

Data updated 2026-11-07.